Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features

Jae-Yong Kwak

Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features

Jae-Yong Kwak

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Current Problems in Cancer
State	Published - 2022.02.1

Cite this

@article{79c8cde27bce4849a27c498701c367c3,

title = "Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features",

author = "Jae-Yong Kwak",

year = "2022",

month = feb,

day = "1",

language = "Korean",

journal = "Current Problems in Cancer",

issn = "0147-0272",

}